Murray, Utah 84157


Purpose:

Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/objectives are as follows: 1. To conduct an unblinded, two-group randomized controlled clinical trial to compare an echocardiography-guided resuscitation protocol with an Early Goal Directed Therapy (EGDT) protocol in patients with severe sepsis or septic shock. 2. Demonstrate that a sepsis treatment protocol using transthoracic echocardiography and other non-invasive assessments of cardiac output will result in more rapid resolution of septic shock compared to invasive EGDT. 3. Demonstrate patients receiving the non-invasive echocardiography protocol will receive less administration of intravenous fluid.


Criteria:

Inclusion Criteria: - At least 18 years of age - Suspected infection - Two or more systemic inflammatory response syndrome (SIRS) criteria - White blood cell count less than 4,000 per mm3, greater than 12,000 per mm3, or differential with greater than 10% immature forms - Heart rate greater than 90 beats per minute - Respiratory rate greater than 20 breaths per minute or paCO2 less than 32 mmHg - Temperature less than 36°C or greater than 38°C - Evidence of refractory hypoperfusion attributed to sepsis (one or more of the following): - Systolic blood pressure less than 90 mmHg despite an intravenous fluid challenge of at least 30ml/kg (a portion of this may be albumin equivalent) - Blood lactate level at least 4 mmol/L. - Intention to place an arterial catheter. - Intention to place a central venous catheter. Exclusion criteria: - Known pregnancy - Requirement for immediate surgery - Hypotension attributed to alternative cause - Treating physician deems the patient is moribund - Treating physician deems aggressive care is unsuitable - Contraindication to central venous catheterization or arterial catheterization - Advanced directives restricting implementation of the protocol - Significant pathology of the chest or abdominal wall that would make transthoracic echocardiography impossible (burns, chest trauma, etc.) - Children under the age of 18 will not be included in this study


NCT ID:

NCT02354742


Primary Contact:

Principal Investigator
Michael Lanspa, MD
Intermountain Health Care, Inc.

Michael Lanspa, MD
Phone: 8015076556
Email: Michael.Lanspa@imail.org


Backup Contact:

Email: valerie.aston@imail.org
Valerie Aston
Phone: (801) 507-4606


Location Contact:

Murray, Utah 84157
United States

Michael Lanspa, MD
Phone: 801-507-6556

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.